Hosting the conversation

Middle East Experience

Latest News

Twenty fined for violating Hajj regulations: Spokesperson

Twenty people have been caught violating the rules and regulations of Hajj and will be subject to a fine of around $2,666 (10,000 Riyals), Saudi Press Agency (SPA) reported on Sunday.For the latest headlines, follow our Google News channel online or via the app.Official spokesperson of Hajj Security Forces Command Brigadier Sami al-Shuwairekh called on all Saudi citizens and residents to follow the instructions put in place for the Hajj season this year, stressing that security personnel will implement regulations set out for people who attempt to reach the Holy Mosque, Holy Sites (Mina, Muzdalifah, Arafat) and surrounding areas without a pre-approved permit.For more coronavirus news, visit our dedicated page.This year’s Hajj is taking place under strict rules and regulations to limit the spread of COVID-19 during the holy pilgrimage. Due to this, only 60,000 pilgrims were accepted to partake in Hajj this year, all of whom had to meet specific criteria.Only vaccinated citizens and residents have been given permission to perform the ritual, with pilgrims all between the ages of 18 and 65, with none suffering from chronic illnesses, while no one has performed Hajj before.Mecca normally welcomes more than 2.5 million Muslims from across the world for Hajj.In 2020, months after the pandemic’s onset, the Kingdom permitted only 10,000 people to take part in the ritual.Read more:Saudi Civil Defense female officers play vital role to ensure safe Hajj seasonNine COVID-19 violators fined $2,666 for attempting to perform Hajj without permitsHajj amid COVID-19: Steps and rituals every pilgrim must follow
Source: Al Arabiya
Full Article: Twenty fined for violating Hajj regulations: Spokesperson

UAE reports 97 pct recovery in COVID-19 Sotrovimab clinical trial 

A clinical trial that examined the use of anti-viral medicine Sotrovimab in the treatment of mild to moderate COVID-19 cases among high-risk patients in the United Arab Emirates found that 97 percent of its recipients fully recovered from the infection within 14 days, Emirates News Agency WAM reported on Sunday. For the latest headlines, follow our Google News channel online or via the app.Fifty percent of the patients selected for the trial were aged 50 and above. Almost all recipients of the Sotrovimab drug had multiple health conditions, including diabetes, cardiovascular disease, cancer and obesity, WAM reported. The monoclonal antibody treatment also resulted in 100 percent prevention of death among recipients and 99 percent reduction in emergency hospitalization. For more coronavirus news, visit our dedicated page.The UAE Ministry of Health, in collaboration with Abu Dhabi’s Department of Health (DoH) and Dubai Health Authority (DHA), examined the efficacy of the medicine as a treatment against COVID-19 in high-risk patients - including children aged 12 and above and pregnant women – by administering it to 6,175 patients in Abu Dhabi.The UAE became one of the first countries in the world to receive a shipment of Sotrovimab in mid-June this year, following its approval by the country’s health ministry and an agreement between Abu Dhabi’s Department of health, leading purchasing organization Rafed, the drug’s manufacturer GlaxoSmithKline (GSK) and Etihad Cargo.Read more:Hajj begins in Saudi Arabia under strict COVID-19 rules for second consecutive yearUAE health officials announce new rules to limit Eid al-Adha COVID-19 spikeUAE records 1,565 COVID-19 cases, four virus-related deaths in 24 hours
Source: Al Arabiya
Full Article: UAE reports 97 pct recovery in COVID-19 Sotrovimab clinical trial